tiprankstipranks
Ocumension Therapeutics (HK:1477)
HKEX:1477
Hong Kong Market

Ocumension Therapeutics (1477) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

1477 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Ocumension
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1477 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:1477 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1477 Financial Forecast

1477 Earnings Forecast

Next quarter’s earnings estimate for 1477 is -HK$0.23 with a range of -HK$0.23 to -HK$0.23. The previous quarter’s EPS was -HK$0.29. 1477 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.32% of the time in the same period. In the last calendar year 1477 has Outperformed its overall industry.
Next quarter’s earnings estimate for 1477 is -HK$0.23 with a range of -HK$0.23 to -HK$0.23. The previous quarter’s EPS was -HK$0.29. 1477 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.32% of the time in the same period. In the last calendar year 1477 has Outperformed its overall industry.

1477 Sales Forecast

Next quarter’s sales forecast for 1477 is HK$182.18M with a range of HK$182.18M to HK$182.18M. The previous quarter’s sales results were HK$154.13M. 1477 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 55.77% of the time in the same period. In the last calendar year 1477 has Underperformed its overall industry.
Next quarter’s sales forecast for 1477 is HK$182.18M with a range of HK$182.18M to HK$182.18M. The previous quarter’s sales results were HK$154.13M. 1477 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 55.77% of the time in the same period. In the last calendar year 1477 has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs
HK$12.41HK$12.25
Buy
78.83%
Upside
Reiterated
03/22/24
Ocumension (1477:HK) PT Lowered to HK$12.25 at Goldman SachsGoldman Sachs analyst Ziyi Chen lowered the price target on Ocumension (1477:HK) to HK$12.25 (from HK$12.41) while maintaining a Buy rating.

Best Analysts Covering Ocumension Therapeutics

Which Analyst Should I Follow If I Want to Buy HK:1477 and Sell After:
1 Month
Ziyi ChenGoldman Sachs
Success Rate
0/3 ratings generated profit
0%
Average Return
-9.43%
reiterated a buy rating 3 months ago
Copying Ziyi Chen's trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -9.43% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Ziyi ChenGoldman Sachs
Success Rate
1/3 ratings generated profit
33%
Average Return
-8.67%
reiterated a buy rating 3 months ago
Copying Ziyi Chen's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -8.67% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Ziyi ChenGoldman Sachs
Success Rate
1/3 ratings generated profit
33%
Average Return
-16.17%
reiterated a buy rating 3 months ago
Copying Ziyi Chen's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -16.17% per trade.
2 Years
Ziyi ChenGoldman Sachs
Success Rate
1/3 ratings generated profit
33%
Average Return
-12.60%
reiterated a buy rating 3 months ago
Copying Ziyi Chen's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -12.60% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1477 Analyst Recommendation Trends

Rating
Mar 23
Aug 23
Mar 24
Strong Buy
1
2
3
Buy
0
0
0
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
total
1
2
3
In the current month, 1477 has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1477 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1477 Stock Forecast FAQ

What is HK:1477’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1477’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1477, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Ocumension Therapeutics a Buy, Sell or Hold?
      Currently, no data Available
      What is Ocumension Therapeutics’s share price target?
      Currently, no data Available
      What do analysts say about Ocumension Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Ocumension Therapeutics?
      To buy shares of HK:1477, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis